Bevacizumab+folfiri as first-line treatment in advanced colorectal cancer (ACC): A multicenter phase II study of the Gruppo Oncologico dell’ Italia Meridionale (prot. GOIM 2601)
Titel:
Bevacizumab+folfiri as first-line treatment in advanced colorectal cancer (ACC): A multicenter phase II study of the Gruppo Oncologico dell’ Italia Meridionale (prot. GOIM 2601)
Auteur:
Giuliani, F. Lorusso, V. De Vita, F. Cinieri, S. Maiello, E. Nugnes, I. del Prete, S. Orditura, M. Leo, S. Addeo, R. Colucci, G.